Registro completo |
Provedor de dados: |
BJMBR
|
País: |
Brazil
|
Título: |
A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies
|
Autores: |
Louzada-Júnior,P.
Freitas,M.V.C.
Oliveira,R.D.R.
Deghaide,N.H.S.
Conde,R.A.
Bertolo,M.B.
Donadi,E.A.
|
Data: |
2008-06-01
|
Ano: |
2008
|
Palavras-chave: |
Susceptibility to rheumatoid arthritis
HLA
Brazilians
Shared epitope
Anti-cyclic citrullinated peptide
|
Resumo: |
The objective of the present study was to evaluate the contribution of the shared epitope (SE), the rheumatoid arthritis (RA) protection model, and the occurrence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in RA patients from a genetically diverse population. One hundred and forty Brazilian RA patients and 161 matched controls were typed for HLA-DRB1 alleles using amplified DNA hybridized with sequence-specific oligonucleotide probes or primers. Patients were stratified according to the presence or absence of SE (DRB1*0401, *0404, *0405, *0101, *1001, and *1402), of the DERAA alleles (DRB1*0103, *0402, *1102, *1103, *1301, *1302, and *1304), and X (all other alleles). Anti-CCP antibodies were measured by ELISA. The combined frequency of SE-positive alleles was significantly greater (76.4 vs 23.6%, P < 0.0001) than the controls. The SE/SE and SE/X genotypes were over-represented (P < 0.0001, OR = 6.02) and DERAA/X was under-represented in RA patients (P < 0.001, OR = 0.49), whereas the frequencies of the SE/DERAA, X/X and X/DERAA genotypes were not significantly different from controls. The frequency of anti-CCP antibodies was higher in SE-positive patients than in SE-negative patients (64.6 vs 44.7%, P = 0.03; OR = 2.25). Although the Brazilian population is highly miscegenated, the results of this study support the findings observed in most genetically homogeneous populations with RA; however, they are not mutually exclusive but rather complementary. The participation of DRB1-DERAA alleles in protection against RA was also observed (OR = 0.4; 95%CI = 0.23-0.68).
|
Tipo: |
Info:eu-repo/semantics/article
|
Idioma: |
Inglês
|
Identificador: |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000600010
|
Editor: |
Associação Brasileira de Divulgação Científica
|
Relação: |
10.1590/S0100-879X2008005000021
|
Formato: |
text/html
|
Fonte: |
Brazilian Journal of Medical and Biological Research v.41 n.6 2008
|
Direitos: |
info:eu-repo/semantics/openAccess
|
|